Hull Hans has filed 8 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 40150 shares of PLIANT THERAPEUTICS, INC. ($PLRX) on January 23, 2025.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 23, 2025 | PLIANT THERAPEUTICS, INC. | $PLRX | Hull Hans | Chief Business Officer | A | Common Stock | 40150 | $0.00 | 283,499.0000 | 0 | 16.50% | 0.00% |
| Jan. 23, 2025 | PLIANT THERAPEUTICS, INC. | $PLRX | Hull Hans | Chief Business Officer | A | Stock Option (Right to Buy) | 80300 | $0.00 | 80,300.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2025 | PLIANT THERAPEUTICS, INC. | $PLRX | Hull Hans | Chief Business Officer | S | Common Stock | 15936 | $11.20 | 243,349.0000 | 0 | 6.15% | 0.00% |
| July 10, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Hull Hans | Chief Business Officer | S | Common Stock | 9900 | $11.56 | 259,285.0000 | 0 | 3.68% | 0.00% |
| July 9, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Hull Hans | Chief Business Officer | A | Common Stock | 19337 | $0.00 | 269,185.0000 | 0 | 7.74% | 0.00% |
| Jan. 23, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Hull Hans | Chief Business Officer | A | Common Stock | 31500 | $0.00 | 248,360.0000 | 0 | 14.53% | 0.00% |
| Jan. 23, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Hull Hans | Chief Business Officer | A | Stock Option (Right to Buy) | 63000 | $0.00 | 63,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Hull Hans | Chief Business Officer | S | Common Stock | 9786 | $17.23 | 216,860.0000 | 0 | 4.32% | 0.00% |